Differences in pathogenicity and clinical syndromes due to Aspergillus fumigatus and Aspergillus flavus.
about
Fungal Aflatoxins Reduce Respiratory Mucosal Ciliary Function.NAC is associated with additional alleviation of lung injury induced by invasive pulmonary aspergillosis in a neutropenic model.High resolution genotyping of clinical Aspergillus flavus isolates from India using microsatellitesCutaneous model of invasive aspergillosis.Multilocus variable-number tandem-repeat analysis of clinical isolates of Aspergillus flavus from Iran reveals the first cases of Aspergillus minisclerotigenes associated with human infection.Antifungal and antihepatotoxic effects of sepia ink extract against oxidative stress as a risk factor of invasive pulmonary aspergillosis in neutropenic miceSimple and highly discriminatory VNTR-based multiplex PCR for tracing sources of Aspergillus flavus isolates.New inhalation-optimized itraconazole nanoparticle-based dry powders for the treatment of invasive pulmonary aspergillosisCutaneous Invasive Aspergillosis: Retrospective Multicenter Study of the French Invasive-Aspergillosis Registry and Literature ReviewCentral Role of IL-23 and IL-17 Producing Eosinophils as Immunomodulatory Effector Cells in Acute Pulmonary Aspergillosis and Allergic Asthma.Colonization with small conidia Aspergillus species is associated with bronchiolitis obliterans syndrome: a two-center validation studyPharmacodynamics of Voriconazole against Wild-Type and Azole-Resistant Aspergillus flavus Isolates in a Nonneutropenic Murine Model of Disseminated Aspergillosis.Diagnosis and treatment of paranasal sinus fungus ball of odontogenic origin: case report.Chronic maxillary rhinosinusitis of dental origin: a systematic review of 674 patient cases.Opportunistic invasive fungal infections: diagnosis & clinical management.Ozone applications to prevent and degrade mycotoxins: a review.Nebulised amphotericin B-polymethacrylic acid nanoparticle prophylaxis prevents invasive aspergillosis.Genetic Diversity and In Vitro Antifungal Susceptibility of 200 Clinical and Environmental Aspergillus flavus Isolates.Molecular variation analysis of Aspergillus flavus using polymerase chain reaction-restriction fragment length polymorphism of the internal transcribed spacer rDNA region.In vitro antifungal susceptibility of clinically relevant species belonging to Aspergillus section Flavi.Variation in clinical phenotype of human infection among genetic groups of Blastomyces dermatitidis.A Novel Y319H Substitution in CYP51C Associated with Azole Resistance in Aspergillus flavus.Fractionation and identification of the allergic proteins in Aspergillus species.Enzymatic and toxigenic ability of opportunistic fungi contaminating intensive care units and operation rooms at Assiut University Hospitals, Egypt.Genetic structure of Aspergillus flavus populations in human and avian isolates.Microsatellite typing of Aspergillus flavus in patients with various clinical presentations of aspergillosis.Characteristics of culture-positive invasive pulmonary aspergillosis in patients with hematologic diseases: Comparison between Aspergillus fumigatus and non-fumigatus Aspergillus species.Aspergillus spp. prevalence in different Portuguese occupational environments: What is the real scenario in high load settings?High-throughput sequencing reveals unprecedented diversities of Aspergillus species in outdoor air.Investigation of multiple resistance mechanisms in voriconazole resistant Aspergillus flavus clinical isolates from a chest hospital surveillance in Delhi, India.Global Aspects of Triazole Resistance in Aspergillus fumigatus with Focus on Latin American Countries.In vitro susceptibility of 188 clinical and environmental isolates of Aspergillus flavus for the new triazole isavuconazole and seven other antifungal drugs.Responding to the emergence of antifungal drug resistance: perspectives from the bench and the bedside
P2860
Q30810957-AFA1746F-DFFE-4133-A359-573516AD1623Q33552719-C3621CC6-1D8D-4340-BF5F-E21BFC95C615Q33802593-98E277F8-DA99-4E72-991E-19D1B9E82AA3Q33826474-106DEE30-1A31-4355-9615-C0E13418F410Q33905034-592DB393-24C3-4704-825F-6CA5EA8CD7FBQ34367333-3DB762E6-332A-4BF8-8BF3-DC46CE217888Q34426975-7F50A0CC-D4F3-499E-B005-4A17BB9DD760Q34456015-37DCD718-A472-4704-9A72-2DB640C310D0Q35857822-79ADDE9E-9270-4B08-BEBE-614085348872Q36251378-9B32D89C-429D-45CA-AA97-12DF566E439EQ36745407-16692A30-2616-421D-89A2-59E9F5B6312EQ37538782-10E8E393-C3AC-4B4D-B509-337C12DF37B6Q37695706-37DCDC6A-FDAB-49D7-A3EC-739E4AB9EE65Q37725565-012FBBB6-0343-41DD-96C7-BC4C7E736925Q37726198-FD4CC0F2-9A23-467A-9294-A987D49D1F84Q37755349-F9F9ECC1-2006-4B68-ACB9-6FCA78970D18Q39027209-2452335F-7107-4482-8777-CB5F836A28B3Q39504883-302449CF-EB1B-4BCE-82FA-B2BEFC021224Q39623156-A638DBAD-74F3-45D1-99DE-BBCDA725998EQ39767031-4F64CF04-52D9-4144-BBDC-5DE49D211910Q40264839-F96AC04E-57D4-49EC-99DD-91F0FA0D1E11Q40653596-B912AF12-330B-401B-819E-D46951545A6CQ41671645-7B8745B8-7F13-45A2-AF73-916717092E3CQ42536792-3CDAC972-AEA0-4453-9694-11E9305C01E1Q43630812-B0AD95FE-5942-431C-B529-495B551270C4Q44423513-D74390AA-FEAB-401E-98BB-B823DC61B9D2Q46240270-6AABA602-36B3-4E35-99FF-3A2B1A662589Q46351891-899956EB-91D7-4A83-9AC4-01525A49E813Q46528789-E44CD59D-9304-41B9-A842-85B3D7FEC95FQ47193266-424CC939-F518-4FF3-A0C9-29896AF6785AQ49167496-046DB86B-5B9E-4594-A590-069D687C2D68Q51037587-1B38E472-3D31-40F5-88DA-6588F01DA237Q58772251-CB69EAC1-3FF1-413B-94E1-D4599D1F3576
P2860
Differences in pathogenicity and clinical syndromes due to Aspergillus fumigatus and Aspergillus flavus.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 July 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Differences in pathogenicity a ...... igatus and Aspergillus flavus.
@en
Differences in pathogenicity a ...... igatus and Aspergillus flavus.
@nl
type
label
Differences in pathogenicity a ...... igatus and Aspergillus flavus.
@en
Differences in pathogenicity a ...... igatus and Aspergillus flavus.
@nl
prefLabel
Differences in pathogenicity a ...... igatus and Aspergillus flavus.
@en
Differences in pathogenicity a ...... igatus and Aspergillus flavus.
@nl
P2860
P1433
P1476
Differences in pathogenicity a ...... igatus and Aspergillus flavus.
@en
P2093
Alessandro C Pasqualotto
P2860
P304
P356
10.1080/13693780802247702
P478
47 Suppl 1
P577
2008-07-24T00:00:00Z